<?xml version="1.0" encoding="UTF-8"?>
<p>The analysis of blood pressure variability data, represented by standard deviation (SD) and average real variability (ARV), showed that supplementation with EVCO was not effective within the assessed groups: SD–MAP: (EVCO (9.27 ± 0.54 vs. 8.73 ± 0.510); Placebo (8.90 ± 0.65 vs. 9.60 ± 0.60); EVCO 
 <italic>plus</italic> training (10.2 ± 0.57 vs. 9.58 ± 0.53) and Placebo 
 <italic>plus</italic> training (9.40 ± 0.64 vs. 9.56 ± 0.60)); and ARV–MAP: (EVCO (6.39 ± 0.33 vs. 5.80 ± 0.28; Placebo (6.22 ± 0.40 vs. 6.50 ± 0.34); EVCO 
 <italic>plus</italic> training (6.57 ± 0.34 vs. 6.07 ± 0.29); and Placebo 
 <italic>plus</italic> training (6.37 ± 0.40 vs. 6.71 ± 0.33)) (
 <xref ref-type="fig" rid="nutrients-13-00798-f004">Figure 4</xref>).
</p>
